2019 Disclosure of Financial Interests

AMA Credit Designation Statement:
The American Society of Addiction Medicine designates this live activity for a maximum of 34.5 AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The American Association for the Treatment of Opioid Dependence (AATOD). The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Attendance at conference events will be verified electronically. Each attendee seeking credits must have his/her conference badge scanned upon entering the meeting room by room monitors and remain for the entire duration of the session. If the attendee leaves the meeting room prior to the conclusion of the session (ex. bathroom break), the badge must be scanned when he/she leaves the room and scanned again when he/she returns for re-entry. No person will receive credit if he/she does not attend the entire session. These monitors will have electronic equipment that will automatically record each individual’s attendance in a database. The database will track and tabulate each attendee’s credits and after the conference, certificates documenting attendance and the number of credits earned will be electronically generated and emailed to all eligible attendees. Successful completion of session attendance will also require the submission of a course evaluation. Questions about continuing education credits can be answered by staff at the Conference Info Desk located in the registration area or contact meetings@aatod.org or 856-423-3091.

There is no conflict of interest for any planner or presenter of this activity except for:
The following individuals have indicated their research activities are sponsored by a company relevant to their presentations vity and/or disclosed a relationship with a commercial company that may be relevant to their presentation. It should not be assumed that these financial interests or relationships will have an adverse impact on faculty presentations. They are noted here simply to fully inform registrants.

S. Cardoos,  Salary, Sage Therapeutics
D. Douglas, Consultant AbbVie, Arbutus Biopharma, Assemblybio, Gilead
B. Feldman, Salary CleanSlate Centers
J. Fields, Consultant Alkermes
S. Gonzalez, Speaker’s Bureau AbbVie
W. Lofwall, Consultant CVS Caremark
D. Marsh, Salary Canadian Addiction Treatment Centres
I. Maremmani, Consultant, Laboratorio Farmaceutico CT Sanremo
Y. Olsen, Consulting Fees Audacious Inquiry
A. Peterson, Consultant Holistic, Inc
J. Renner, Consultant The Bizzell Group, American Psychiatric Association, General Electric, Johnson & Johnson
A. Talal, Consultant Abbott, AbbVie, Chronic Liver Disease Foundation, Merck
N. Van Dyke, Salary BayMark Health Services

As supporters of #MedicationAssistedTreatment, we understand the dangers of allowing methadone – a Schedule II narcotic – to be distributed at local pharmacies. 
ACT NOW by telling Congress to protect the #OTP standard of care & our communities: https://programnotapill.com/write-congress/ #PNAP

Load More...

#aatod2022 conference

225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
Follow by Email

Stay Connected to AATOD